Similar articles for PMID: 34645806

Year	Number of Results
1998	1
2005	1
2007	1
2008	3
2009	4
2010	3
2011	4
2012	11
2013	7
2014	18
2015	14
2016	9
2017	7
2018	5
2019	8
2020	6
2021	2
2022	1
2024	0

1

Cancer gene mutation frequencies for the U.S. population.

Mendiratta G, Ke E, Aziz M, Liarakos D, Tong M, Stites EC. Mendiratta G, et al. Nat Commun. 2021 Oct 13;12(1):5961. doi: 10.1038/s41467-021-26213-y. Nat Commun. 2021. PMID: 34645806 Free PMC article.

2

Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.

Løes IM, Immervoll H, Sorbye H, Angelsen JH, Horn A, Knappskog S, Lønning PE. Løes IM, et al. Int J Cancer. 2016 Aug 1;139(3):647-56. doi: 10.1002/ijc.30089. Epub 2016 Apr 4. Int J Cancer. 2016. PMID: 26991344 Free PMC article.

3

Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.

Jauhri M, Bhatnagar A, Gupta S, Bp M, Minhas S, Shokeen Y, Aggarwal S. Jauhri M, et al. Tumour Biol. 2017 Feb;39(2):1010428317692265. doi: 10.1177/1010428317692265. Tumour Biol. 2017. PMID: 28222664 Free article.

4

Identification of molecular targets in vulvar cancers.

Palisoul ML, Mullen MM, Feldman R, Thaker PH. Palisoul ML, et al. Gynecol Oncol. 2017 Aug;146(2):305-313. doi: 10.1016/j.ygyno.2017.05.011. Epub 2017 May 20. Gynecol Oncol. 2017. PMID: 28536037

5

Genomic and Molecular Abnormalities in Gynecologic Clear Cell Carcinoma.

Marks EI, Brown VS, Dizon DS. Marks EI, et al. Am J Clin Oncol. 2020 Feb;43(2):139-145. doi: 10.1097/COC.0000000000000641. Am J Clin Oncol. 2020. PMID: 31764020 Review.

6

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R. Velho S, et al. BMC Cancer. 2008 Sep 9;8:255. doi: 10.1186/1471-2407-8-255. BMC Cancer. 2008. PMID: 18782444 Free PMC article.

7

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.

Janku F, Lee JJ, Tsimberidou AM, Hong DS, Naing A, Falchook GS, Fu S, Luthra R, Garrido-Laguna I, Kurzrock R. Janku F, et al. PLoS One. 2011;6(7):e22769. doi: 10.1371/journal.pone.0022769. Epub 2011 Jul 29. PLoS One. 2011. PMID: 21829508 Free PMC article.

8

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.

Guedes JG, Veiga I, Rocha P, Pinto P, Pinto C, Pinheiro M, Peixoto A, Fragoso M, Raimundo A, Ferreira P, Machado M, Sousa N, Lopes P, Araújo A, Macedo J, Alves F, Coutinho C, Henrique R, Santos LL, Teixeira MR. Guedes JG, et al. BMC Cancer. 2013 Apr 1;13:169. doi: 10.1186/1471-2407-13-169. BMC Cancer. 2013. PMID: 23548132 Free PMC article.

9

Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.

Kleist B, Kempa M, Novy M, Oberkanins C, Xu L, Li G, Loland C, Poetsch M. Kleist B, et al. Int J Clin Exp Pathol. 2014 Aug 15;7(9):5927-39. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25337237 Free PMC article.

10

Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.

Tsilimigras DI, Ntanasis-Stathopoulos I, Bagante F, Moris D, Cloyd J, Spartalis E, Pawlik TM. Tsilimigras DI, et al. Surg Oncol. 2018 Jun;27(2):280-288. doi: 10.1016/j.suronc.2018.05.012. Epub 2018 May 8. Surg Oncol. 2018. PMID: 29937183 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year